Gossamer Bio, Inc. - stock earnings
GOSS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -48.1 million USD | ? USD |
| 2023Q3 | -40.0 million USD | ? USD |
| 2023Q2 | -42.5 million USD | ? USD |
| 2023Q1 | -53.9 million USD | ? USD |
| 2022Q4 | -57.2 million USD | ? USD |
| 2022Q3 | -62.7 million USD | ? USD |
| 2022Q2 | -59.1 million USD | ? USD |
| 2022Q1 | -61.2 million USD | ? USD |
| 2021Q4 | -56.3 million USD | ? USD |
| 2021Q3 | -60.2 million USD | ? USD |
| 2021Q2 | -59.8 million USD | ? USD |
| 2021Q1 | -57.6 million USD | ? USD |
| 2020Q4 | -64.6 million USD | ? USD |
| 2020Q3 | -57.8 million USD | ? USD |
| 2020Q2 | -66.9 million USD | ? USD |
| 2020Q1 | -54.1 million USD | ? USD |
| 2019Q4 | -54.7 million USD | ? USD |
| 2019Q3 | -48.5 million USD | ? USD |
| 2019Q2 | -44.5 million USD | ? USD |
| 2019Q1 | -32.6 million USD | ? USD |
| 2018Q4 | -38.8 million USD | ? USD |
| 2018Q3 | -49.4 million USD | ? USD |
| 2018Q2 | -32.7 million USD | ? USD |
| 2018Q1 | -26.0 million USD | ? USD |
| 2017Q4 | -6.5 million USD | ? USD |
GOSS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -179.8 million USD | ? USD |
| 2022 | -240.2 million USD | ? USD |
| 2021 | -249.1 million USD | ? USD |
| 2020 | -251.6 million USD | ? USD |
| 2019 | -180.8 million USD | ? USD |
| 2018 | -147.0 million USD | ? USD |
| 2017 | -6.8 million USD | ? USD |
| 2016 | -83000 USD | ? USD |
GOSS
Price: $0.67
52 week price:
Earnings Per Share: -1.18 USD
P/E Ratio: -0.54
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 916653
Market Capitalization: 203.2 million